Related Experiment Video
Updated: Nov 10, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.3K
The Role of ASIC1a in Epilepsy: A Potential Therapeutic Target
Yu Cheng1, Wuqiong Zhang1, Yue Li1
1Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun, China.
Current Neuropharmacology
|April 2, 2021
Summary
Acid-sensing ion channel-1a (ASIC1a) plays a role in epilepsy, though its exact function is debated. Further research into ASIC1a
Area of Science:
- Neuroscience
- Molecular Biology
- Pathophysiology
Background:
- Epilepsy is a common neurological disorder characterized by recurrent seizures.
- Tissue acidosis is frequently observed in epilepsy foci, but its role in epileptogenesis is not fully understood.
- Acid-sensing ion channel-1a (ASIC1a) is a proton-gated cation channel expressed in the mammalian brain, implicated in various neurological conditions.
Purpose of the Study:
- To review the structure, trafficking, and molecular mechanisms of ASIC1a.
- To elucidate the role of ASIC1a in the context of epilepsy.
- To explore ASIC1a as a potential therapeutic target for epilepsy.
Main Methods:
- Literature search conducted across Web of Science, Medline, and PubMed.
- Keywords used included "Acid-sensing ion channels 1a" or "ASIC1a" and "epilepsy" or "seizure".
Main Results:
- The precise role of ASIC1a in epilepsy remains a subject of ongoing research and debate.
- ASIC1a presents as a potential therapeutic target for epilepsy management.
Conclusions:
- A comprehensive understanding of ASIC1a's structure and function is crucial for its therapeutic application in epilepsy.
- Further investigation is warranted to fully elucidate ASIC1a's involvement in epileptogenesis and its potential as a drug target.
More Related Videos
09:49Using a Bipolar Electrode to Create a Temporal Lobe Epilepsy Mouse Model by Electrical Kindling of the Amygdala
Published on: June 29, 2022
2.8K
09:39Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
Published on: June 7, 2016
10.8K
Related Concept Videos
01:24Epilepsy and Seizures: Overview
792
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
792
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
904
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
904
01:14Antiepileptic Drugs: Glutamate Antagonists
657
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
657
01:17Antiepileptic Drugs: Calcium Channel Blockers
827
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
827
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
580
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
580
01:20Antiepileptic Drugs: Potassium Channel Activators
408
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
408